Miranda Schmalfuhs

Telehealth & Its Role in Providing Access to Weight Loss Drugs

In this part of their Pharmaceutical Executive video interview, UpScriptHealth's Peter Ax, Founder and CEO, and George Jones, Chief Operations Officer, share their predictions for the future of telehealth and its role in providing access to essential medications like weight loss drugs.

Survey: One-Third of Adults Say They Don’t Need Fall Vaccines

An Ohio State University survey found that many adults are hesitant about getting flu, COVID-19, pneumococcal and respiratory syncytial virus (RSV) vaccines.

Can AI Companions Help Cure the Loneliness Epidemic?

Companion apps promise to keep you company. We decided to put them to the test.

Advanced Clinical Named One of Crain’s Best Places to Work in Chicago 2024

Advanced Clinical, a privately-held clinical development and strategic resourcing organization committed to providing a better clinical experience across the drug development journey, is pleased to share that we’ve been named one of Crain’s Best Places to Work in Chicago 2024.

I'm excited to share a new thought leadership article I wrote in partnership with Yakir Siega land Gregory Lief! I'm beyond thrilled to see it published in Pharmaceutical Executive magazine where it will reach a broad range of leaders in the industry. My deep gratitude goes out to Yakir and Greg for believing in this piece and empowering me to share my research and perspectives.

Have news you want us to share in Pharma Pulse? Reach out to Social Media Editor 

Articles

The latest news for pharma industry insiders.

Pharma Pulse 9/18/24: Telehealth's Role in Access to Weight Loss Drugs, Can AI Companions Help Cure Loneliness? & more

Increasing Access to Legitimate Weight Loss Medications

In this part of their Pharmaceutical Executive video interview, UpScriptHealth's Peter Ax, Founder and CEO, and George Jones, Chief Operations Officer, discuss how UpScriptHealth is working to increase access to legitimate weight loss medications, especially for those in underserved communities.

FDA Warns of Liver Injury with Veozah for Hot Flashes

The FDA has identified a probable case of serious drug induced liver injury that occurred in a woman in the United States who had received Veozah. The agency is requiring additional liver blood testing after starting therapy.

Roche Shares Slump on Oral Weight-Loss Drug Candidate Side Effects

The company said the drug was generally well tolerated, but some patients showed gastrointestinal side effects that were consistent with similar drugs at an early stage of development.

The number of connected home medical monitoring devices on the global market was 76.7 million at the end of 2023 and is forecasted to grow at a CAGR of 12.8 percent in the next five years to reach 140.1 million in 2028.

The adoption of mHealth solutions in healthcare is driven by a wide range of incentives, related to everything from demographics and technology development to new advancements in medical treatment. The primary focus of this report is on home monitoring solutions, which are commonly used to manage patients with various chronic conditions such as cardiac arrhythmia, sleep apnoea and diabetes. Other applications include remote diagnostics, compliance monitoring and clinical trials.

Very inspiring article Cristina Ortega Duran. I couldn't agree more—understanding key pain points and co-creating solutions with patients are crucial for ensuring success and global scalability. A diverse team and new WoW are essential enablers for driving meaningful innovation 👏 👏 👏

Pharma Pulse 9/17/24: mHealth and Home Monitoring Report, Increasing Access to Legitimate Weight Loss Medications & more

Copay Adjustment Chess Match: What Will Payers Do Next?

As new litigation looms in the debate over use of copay accumulator programs, a look at potential next moves for payers—and steps drug manufacturers should take to ward off cost-driven non-adherence.

Pharmacy Focus: Alzheimer Drug Pipeline Expands, Promising Therapies in Development

The Alzheimer disease treatment landscape is evolving with new FDA-approved antibody therapies and advancements in biomarker testing to enable earlier diagnosis and intervention.

Hopeful News for Users of One A.D.H.D. Drug

The D.E.A. is increasing its quota for Vyvanse as patients still struggle to fill prescriptions.

Advanced eClinical Training Partners with The Education Fund to Expand Educational Opportunities for Healthcare Workers

This collaboration provides union healthcare workers with access to high-demand Allied Health certifications through short-term online and blended programs.


Tickets are now on sale for the 2024 Pharmaceutical Executive® APEX Awards!

Get ready for an unforgettable night at the New York Hilton Midtown, NYC on November 13! Don't miss out — be part of a night honoring the best in healthcare marketing.

Grab your tickets today: 



#PharmaMarketing #HealthcareMarketing #PEAPEXAwards

Pharma Pulse 9/16/24: Copay Adjustment Chess Match, Alzheimer Drug Pipeline Expands & more

Making the Leap from Pharmaceuticals to Private Equity, Venture Capital

A Harvard Business School Healthcare Alumni Association Q&A with Jeremy Goldberg of Arsenal Capital Partners.

Black Patients Have Greater Risk of Dying From GVHD Than White Patients

The retrospective analysis found Black patients were more likely to develop severe graft versus host disease (GVHD) and have a higher risk of nonrelapse mortality than White patients after hematopoietic stem cell transplantation.

OpenAI’s Fund-Raising Talks Could Value Company at $150 Billion

The San Francisco start-up hopes to raise $6.5 billion as part of an aggressive push for more investment.

Dr.Evidence Unveils Major Enhancements to AI-enabled Landscape Intelligence Platform for Life Sciences

Dr.Evidence announced significant enhancements to further accelerate clients’ time-to-market for new drugs and indications and de-risk the possibility of missing critical precedent from the market to support a successful path to approval.

In an interview with Pharmaceutical Commerce Magazine Editor, Nicholas Saraceno, Archbow Consulting Vice President Meghan Mullooly, outlines the various #digitalsolutions available to drive efficiencies when delivering #PatientServices.

Stay tuned for Part II of their interview!